Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03977779

Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

Prospective Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
46 (estimated)
Sponsor
Institut Paoli-Calmettes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The use of an endoprothesis in a pancreatic duct is a measure to minimize the incidence and severity of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis. In this study we will evaluate the use of a Biodegradable Endoprothesis: Archimede Fast Biodegradable Pancreatic Stent in patients with high risk of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis.The ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography. The efficacy and the security of the device will be evaluated.

Conditions

Interventions

TypeNameDescription
DEVICEPlacement of ARCHIMEDES fast biodegradable stent during the Endoscopic Retrograde CholoangioPancreatographyThe ARCHIMEDES Fast biodegradable pancreatic stent will be placed during the Endoscopic Retrograde CholoangioPancreatography

Timeline

Start date
2022-01-20
Primary completion
2024-12-01
Completion
2024-12-15
First posted
2019-06-06
Last updated
2024-10-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03977779. Inclusion in this directory is not an endorsement.